Skip to content
Dosage GuideResearch Reference

DSIP Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for DSIP. All information is for educational purposes only.

Quick Answer

In preclinical research, DSIP is typically administered at 50–200 mcg per dose via subcutaneous injection, often before bedtime. Oral formulations have also been explored at slightly higher doses due to bioavailability considerations. No human clinical dose-ranging trials have been completed, and most data is extrapolated from animal studies or anecdotal reports.

→ DSIP Benefits→ DSIP Side Effects→ Full DSIP Profile
Table of Contents

Standard Dosage Range

Research dosing range: 50–200 mcg per dose (injection); 100-300 mcg (oral)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Sleep Improvement

50–100 mcg1× daily
Duration

2–4 weeks

Administer subcutaneously 30-60 minutes before bedtime. Start with a lower dose to assess individual sensitivity.

Stress Reduction

50–150 mcg1× daily
Duration

2–4 weeks

Administer subcutaneously in the evening, may help regulate HPA axis activity. Monitor cortisol levels if possible.

Pain Management

100–200 mcg1× daily
Duration

2–4 weeks

Administer subcutaneously, effects may be potentiated with other analgesics. Monitor pain levels closely.

Alcohol Withdrawal Support

100-200 mcg1-2x daily
Duration

Up to 7 days during acute withdrawal

Based on preliminary research. Administer subcutaneously. Should be used in conjunction with standard medical protocols for alcohol withdrawal.

Timing & Frequency

DSIP is best administered 30-60 minutes before bedtime to align with its sleep-promoting effects. Consistent timing each day can help regulate the circadian rhythm. For stress-related applications, evening administration is generally preferred.

Cycle Guidance

Most preclinical studies used short-term protocols (2-4 weeks). Given the limited long-term human safety data, cycling is a prudent approach. A common approach involves a 4-week cycle followed by a 2-week break. Monitoring sleep quality and stress levels can help guide cycle length and frequency.

Reconstitution Reference

Quick reference for reconstituting DSIP. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically 1-2 mg per vial
BAC Water Volume1 mL bacteriostatic water for 1-2 mg/mL concentration
Concentration & DrawAt 1 mg/mL: 100 mcg = 0.1 mL (10 units on a 100-unit insulin syringe)
StorageRefrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
StabilityReconstituted solution stable up to 7-10 days refrigerated. Lyophilized powder stable 12-24 months per manufacturer specifications.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the best time to take DSIP?
DSIP is best administered 30-60 minutes before bedtime to capitalize on its sleep-promoting effects. This allows the peptide to start working as you are preparing to sleep.
How long does DSIP take to work?
While the plasma half-life of DSIP is short (~15 minutes), its effects on sleep architecture can be observed within 30-60 minutes of administration. Individual responses may vary.
Can I take DSIP orally?
Oral formulations are being explored, but bioavailability is lower compared to subcutaneous injection. If taken orally, a slightly higher dose may be required. Sublingual administration may offer improved absorption compared to swallowing.
Are there any side effects associated with DSIP?
Side effects are generally mild but can include headache, mild nausea, or changes in dream vividness. More research is needed to fully characterize the potential side effect profile.

Last updated: 2026-02-19